Specialty Generics Operating Division News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Intercept Appoints Jared M. Freedberg as General Counsel and Secretary
Intercept Pharmaceuticals, Inc.January 11, 2021 GMT
NEW YORK, Jan. 11, 2021 (GLOBE NEWSWIRE) Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced the appointment of Jared M. Freedberg as General Counsel and Secretary. Mr. Freedberg joins Intercept from Immunomedics, Inc., which was acquired by Gilead Sciences in October of 2020.
“I am very pleased to welcome Jared to the Intercept team as we begin a pivotal year for the company,” said Jerry Durso, President and Chief Executive Officer of Intercept. “His substantial legal and business development expertise will be invaluable as we focus on enhancing the growth of our foundational PBC busines ....

New York , United States , Jerry Durso , Lisa Defrancesco , Christopher Frates , Jaredm Freedberg , Leadership Team For Immunomedics , Mallinckrodt Pharmaceuticals , Specialty Generics Operating Division , Drug Administration , Exchange Commission , Immunomedics Inc , Intercept Pharmaceuticals Inc , Covance Inc , Securities Exchange , Business Development , General Counsel , Gilead Sciences , Chief Executive Officer , Executive Leadership Team , New Drug Application , Vice President , Global Executive Leadership Team , Securities Act , Securities Exchange Act , Annual Report ,